Profile
Jonathan Thon is the founder of Stellular Bio, Inc. (founded in 2014) and STRM.Bio, Inc. (founded in 2019).
He holds the title of Chief Scientific Officer at Stellular Bio, Inc. and President, CEO, Treasurer, Secretary & Director at STRM.Bio, Inc. Additionally, Dr. Thon is currently working as a Director at Optiva Fertility, Inc.
Jonathan Thon active positions
Companies | Position | Start |
---|---|---|
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Founder | 2013-12-31 |
STRM.Bio, Inc.
STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Chief Executive Officer | 2019-09-30 |
Optiva Fertility, Inc. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
STRM.Bio, Inc.
STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |
Optiva Fertility, Inc. |
- Stock Market
- Insiders
- Jonathan Thon